Precision BioSciences, Inc. (DTIL)
7.80
-0.60
(-7.14%)
USD |
NASDAQ |
Aug 28, 16:00
7.80
0.00 (0.00%)
After-Hours: 17:50
Precision BioSciences Price to Book Value : 4.552 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 4.902 |
| August 26, 2026 | 4.955 |
| August 25, 2026 | 4.990 |
| August 24, 2026 | 4.932 |
| August 21, 2026 | 5.165 |
| August 20, 2026 | 5.089 |
| August 19, 2026 | 4.961 |
| August 18, 2026 | 4.803 |
| August 17, 2026 | 4.319 |
| August 14, 2026 | 4.336 |
| August 13, 2026 | 4.260 |
| August 12, 2026 | 4.330 |
| August 11, 2026 | 4.383 |
| August 10, 2026 | 4.354 |
| August 07, 2026 | 4.371 |
| August 06, 2026 | 4.330 |
| August 05, 2026 | 4.360 |
| August 04, 2026 | 4.249 |
| August 03, 2026 | 4.120 |
| July 31, 2026 | 4.079 |
| July 30, 2026 | 4.085 |
| July 29, 2026 | 4.021 |
| July 28, 2026 | 4.184 |
| July 27, 2026 | 4.231 |
| July 24, 2026 | 4.254 |
| Date | Value |
|---|---|
| July 23, 2026 | 4.278 |
| July 22, 2026 | 4.272 |
| July 21, 2026 | 4.447 |
| July 20, 2026 | 4.295 |
| July 17, 2026 | 4.593 |
| July 16, 2026 | 4.856 |
| July 15, 2026 | 5.142 |
| July 14, 2026 | 5.007 |
| July 13, 2026 | 5.013 |
| July 10, 2026 | 5.112 |
| July 09, 2026 | 5.346 |
| July 08, 2026 | 5.416 |
| July 07, 2026 | 5.398 |
| July 06, 2026 | 4.809 |
| July 02, 2026 | 4.774 |
| July 01, 2026 | 4.599 |
| June 30, 2026 | 4.587 |
| June 29, 2026 | 2.686 |
| June 26, 2026 | 2.472 |
| June 25, 2026 | 2.289 |
| June 24, 2026 | 2.286 |
| June 23, 2026 | 2.357 |
| June 22, 2026 | 2.401 |
| June 18, 2026 | 2.309 |
| June 17, 2026 | 2.204 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amgen, Inc. | 20.00 |
| 4D Molecular Therapeutics, Inc. | 1.987 |
| Agenus, Inc. | -- |
| Anika Therapeutics, Inc. | 2.063 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.527 |
| Price | 7.80 |
| Earnings Yield | -36.53% |
| Market Cap | 206.18M |